Understanding the relationship between GLP-1 medications and skin reactions helps patients distinguish between documented adverse effects, injection site reactions, and changes related to weight loss
During this 'sweet spot' window, you'll experience maximum appetite suppression and sustained lower food intake without white-knuckling hunger
Some patients start noticing results within 23 months, with clinical studies showing an average of 14.9% body weight loss after 68 weeks
To support digestive comfort, focus on small, slower meals
A PlexusDx provider can assess your individual likelihood of success and recommend either tapering, maintenance therapy, or a personalized transition plan
How to Schedule Your Visit Patients can schedule appointments in person or virtually, depending on preference and medical need